Építés alatt – nem éles oldal
Belépés
BefejeződöttFázis nélkül

Results of Progressive Resistance Training in Older Type 2 Diabetic Patients With Sarcopenia

A legfontosabb adatok

Ki végzi
National Geriatric Hospital
Hol
Hanoi (Vietnám)A helyszín megnézése
Azonosító
Állapot
Befejeződött
Résztvevők
70 fő vett részt
Kezdés
2024. máj. 1.
Befejezés
2025. dec. 31.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport nem kap vizsgálati kezelést, összehasonlításként.
A vizsgált kezelések
  • Progressive Resistance Training
A regiszteradat frissítve
2026. november 12.

Ki vehet részt

Életkor
60 év – 80 év
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 11 feltétel megnézéseKevesebb

Ki vehet részt

  • Type 2 diabetic patients diagnosed using American Diabetes Association 2022 criteria
  • HbA1c ≥ 7.0 and ≤ 8.5%
  • Sarcopenia diagnosed using criteria from the Asian Working Group for Sarcopenia 2019
  • Age ≥ 60 and ≤ 80

Ki nem vehet részt

  • Patients are in the acute phase of musculoskeletal disorders: acute gout, progressing rheumatoid arthritis, acute joint pain due to joint degeneration, sciatic pain, and infectious arthritis
  • Patients suffer from conditions significantly affecting cognition and mobility: sequelae of stroke (with weakness, limb paralysis), muscular weakness, limb disabilities, severe heart failure, severe cognitive decline, and psychiatric disorders
  • Patients have been bedridden due to illness for more than 1 month within the past 3 months up to the recruitment time
  • Patients with cardiovascular diseases: chest pain, uncontrolled blood pressure ≥160/100 mmHg, untreated cardiac arrhythmia, a history of congestive heart failure, severe valvular heart disease, myocarditis or pericarditis, and hypertrophic cardiomyopathy
  • Renal failure with estimated glomerular function rate (Modification of Diet in Renal Disease equation) < 60 ml/min/m3 or serum creatinine ≥ 130 µmol/l
  • On treatment with Sodium-glucose cotransporter 2 inhibitors (SGLT2i) or GLP-1 receptor agonists
  • Acute diabetic complications

Helyszínek itt: Vietnám

  • National Geriatric HospitalHanoi, Vietnám

A vizsgálatról

Mit akar kideríteni a vizsgálat

A randomized controlled clinical trial that will test how progressive resistance training will impact outcomes of sarcopenia in older patients with type 2 diabetes who have been diagnosed as sarcopenia. The intervention will be 12 weeks in duration with approximately 24 sessions of resistance exercises. Outcome measures will be collected at baseline, 4, 8 weeks and 12 weeks.

A vizsgálat 2 csoportja

  • Intervention groupA vizsgált kezelés

    The intervention group receives supervised resistance training instructions and baseline treatment for sarcopenia and diabetes: * Resistance training with elastic bands aims to increase muscle strength and muscle mass of the upper and lower limbs. Training duration 12 weeks, frequency 2 times/week, intensity gradually increases. * Baseline treatment for diabetes and sarcopenia: Recommendations according to American Diabetes Association guidelines which include instructions to follow the diet and exercises as recommended for older type 2 diabetic patients and baseline treatment for sarcopenia (education about sarcopenia and treatment measures such as diet and exercise) and provide basic information on resistance training.

    Kezelés: Progressive Resistance Training

  • Control groupNincs vizsgálati kezelés, összehasonlításként

    The control group receives the baseline treatment for diabetes and sarcopenia: \- Recommendations according to American Diabetes Association guidelines which include instructions to follow the diet and exercises as recommended for older type 2 diabetic patients and baseline treatment for sarcopenia (education about sarcopenia and treatment measures such as diet and exercise) and provide basic information on resistance training.

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Evaluating Resistance Training for Sarcopenia in Older Patients With Type 2 Diabetes: Treatment Outcomes
A regiszteradat frissítve
2026. november 12.